Hospital Analyzer Articles & Analysis
6 news found
When most people think of hospital data, they think of data that relates directly to the patients: demographics, diagnosis, lengths of stay, etc. This information is relatively easy to collect, and it is useful when providing treatment and looking at overall trends for care. Other hospital data can be more challenging to gather accurately, but is critical to answering important questions that ...
ByBioVigil
The Secure Anonymised Information Linkage (SAIL) Databank holds a wealth of anonymised data collected from people in Wales over the past 30 years. This data comes from health and social care, care homes, registers and audits, specialist services and surveys, which can be anonymously linked to provide a clear picture of the health and social care setting in Wales. SAIL data has been used widely ...
Post hoc analyses conducted in patient populations at greater risk of progression to severe disease or death suggests that SNG001 may have an important clinical effect on top of standard of care Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces the ...
Kheiron Medical Technologies today announced the hire of Dr. Ben Glocker for the position of Head of Machine Learning Research. In his role, Glocker will lead Kheiron’s work to develop AI solutions that are designed to give patients a better fighting chance against cancer. He will also support Kheiron’s work to ensure these solutions help groups that are underrepresented in the ...
4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, has extended its existing partnership with the University of Leeds in the UK through 2027, the two organizations announced today. Through a prior three-year partnership, 4D Path has already successfully completed three breast cancer clinical studies at Leeds with striking results. Cases from over ...
Production capacity of hematology reagents is to be doubled Handle expansion in medical services driven by economic growth HORIBA Group's local subsidiary in Brazil, HORIBA ABX Ltda. (1), acquired a 10,000 m2 site(2) on the outskirts of Sao Paolo, Brazil, and will construct a plant there for the manufacture of hematology reagents(3) for hospitals where hematology analyzers are used. The intent ...